Merck names Miguel Alcalde to lead global commercial strategy; Monia Vial to head North America
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
The appointments come as Andrew Paterson, who has spent 31 years with the company, prepares to retire
The approval is based on results from the pivotal Phase 3 KEYNOTE-905 trial
Backed by Phase 3 trial showing 24% lower risk of progression
Company secures 7th position nationwide in India's Great Mid-size Workplaces 2026, reinforcing its people-first culture as it marks 75 years of excellence
In his 17-year career within Roche, Marco has held key global, regional, and affiliate leadership roles
Partnership with MAMTA HIMC aims to boost awareness, screening, HPV vaccination, and early detection of breast and cervical cancer in underserved communities
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
The company plans to use this funding to boost AI capabilities, expand vernacular content ecosystem, accelerate product development, and scale user acquisition across Tier 2 and Tier 3 markets
Intas Pharmaceuticals has appointed Girish Bhunje as Senior Vice President – API Operations
Rathi brings more than 15 years of experience in formulation research and development, with deep expertise across a wide range of dosage forms and drug delivery technologies.
Subscribe To Our Newsletter & Stay Updated